Head of the Drug Discovery Incubator, Research and Early Development @ (January 2016 - January 2020)
Head of the Immunopharmacology Group @ (January 2006 - January 2011)
Independent Consultant to biotech and pharma industry (January 2020 - January 2020)
Co-Founder @ Zeylexa LLC (January 2019 - January 2020)
Head of Immunology Research and Discovery Biomarker Group, Immunology Research @ (January 2011 - January 2016)
Dania Rabah Education
Virginia Commonwealth University School of Medicine
Doctor of Philosophy (Microbiology, Immunology)
1996-2001
American University of Beirut
Master of Science (Immunology)
1993-1996
American University of Beirut
Bachelor of Science (Biology)
1989-1992
Dania Rabah Skills
Immunology
Monoclonal Antibodies
Drug Discovery
Biopharmaceuticals
Biotechnology
In Vivo
Antibodies
ELISA
Translational Research
Assay Development
Cell Culture
Cell
Flow Cytometry
In Vitro
Immunoassays
Cell Biology
Animal Models
Biomarkers
Protein Chemistry
Inflammation
Dania Rabah Summary
Dania Rabah, based in Boston, MA, US, is currently a Co-founder at Biotech NewCo | Atlas Venture EIR at Atlas Venture. Dania Rabah brings experience from previous roles at Rheos Medicines, Biogen and Self Employed. Dania Rabah holds a 1996 - 2001 Doctor of Philosophy in Microbiology, Immunology @ Virginia Commonwealth University School of Medicine. With a robust skill set that includes Immunology, Monoclonal Antibodies, Drug Discovery, Biopharmaceuticals, Biotechnology and more. Dania Rabah has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Dania Rabah?
Find contact details for 700 million professionals.